Pharmacology has been at it a long time. Precursor to the Western pill-based prescription for all that ails, it stands on the shoulders of a thousands-generations long compilation of the knowledge of ...

In this week’s edition of InnovationRx, we look at Aetna’s withdrawal from the ACA exchanges, the potential for digital ...

The nationwide withdrawal, affecting roughly 1 million people in the United States, comes amid chaos in the government health ...

CVS Health (CVS) stock in focus as Glenview Capital trims a third of its stake after the company's Q1 2025 earnings beat.

CVS stock has an attractive yield and earnings expansion. That makes it worth a look for investors seeking growth and income.

Payer profits fell in 2024 as Americans, especially older ones, utilized more medical care. But efforts to resuscitate ...